DrugSep 27, 2023
Novartis Pharmaceuticals SANDIMMUNE Oral Solution recall — FDA D-1174-2023
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.
Class IFDA: OngoingNovartis Pharmaceuticals Corp.
Recall history in this database
Classification mix: Class II: 15, Class III: 7, Class I: 2.
DrugMay 29, 2019
Promacta (eltrombopag) 12.5 mg for Oral Suspension recall — FDA D-1309-2019
Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.
Class IFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugSep 23, 2015
Novartis Pharmaceuticals Dexmethylphenidate HCl Extended-Release, Capsules, 10mg recall — FDA D-1430-2015
Failed Dissolution Specifications: Product is being recalled due to out of specification (above specification) result obtained at 6-hour dissolution time point during the 12-month stability…
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugJun 24, 2015
Novartis Pharmaceuticals Foradil Aerolizer recall — FDA D-1138-2015
Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugJun 24, 2015
Novartis Pharmaceuticals Foradil Aerolizer recall — FDA D-1137-2015
Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugAug 13, 2014
Novartis Pharmaceuticals Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles recall — FDA D-1516-2014
Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugJun 25, 2014
Novartis Pharmaceuticals Foradil Aerolizer recall — FDA D-1387-2014
Failed Stability Specification; out of specification result for particle size distribution during stability testing
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugApr 16, 2014
Novartis Pharmaceuticals Ritalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per recall — FDA D-1227-2014
Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR…
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugApr 16, 2014
Novartis Pharmaceuticals Ritalin HCl (methylphenidate HCl) USP, 20 mg, 100 tablets per recall — FDA D-1228-2014
Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR…
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Exforge HCT recall — FDA D-332-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Tekturna (aliskiren) Tablets 150 mg, 7 tablets per bottle recall — FDA D-337-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Stalevo recall — FDA D-336-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Exforge recall — FDA D-328-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Exforge recall — FDA D-333-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Exforge HCT recall — FDA D-331-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Exforge recall — FDA D-334-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Exforge HCT recall — FDA D-330-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Diovan (valsartan) 160 mg per tablet, 7 Tablets per bottle recall — FDA D-326-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Tekturna HCT recall — FDA D-339-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Lescol XL (fluvastatin sodium) Extended-Release Tablets, 80 mg per recall — FDA D-335-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Diovan (valsartan) 320 mg per tablet, 7 Tablets per bottle recall — FDA D-327-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Tekturna HCT recall — FDA D-340-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Exforge recall — FDA D-329-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
DrugDec 18, 2013
Novartis Pharmaceuticals Tekturna (aliskiren) Tablets 300 mg, 7 tablets per bottle recall — FDA D-338-2014
Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due…
Class IIFDA: TerminatedNovartis Pharmaceuticals Corp.
Understanding this recall history
This page summarizes recall records in which the official source identifies Novartis Pharmaceuticals Corp. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.